Clinical Trial Update: A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain [Phase 4]

View source ↗

Summary

Phase 4 randomized study comparing pregabalin sustained release vs immediate release in type 2 diabetes patients with peripheral neuropathic pain; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Type 2 Diabetes Mellitus

Drugs mentioned

• Pregabalin Immediate Release Capsule (pregabalin)
• Pregabalin sustained release tablet (pregabalin)

Snippet

Sponsor: Yuhan Corporation | Conditions: Neuropathic Pain, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED